Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

B&L patent settlement

This article was originally published in The Tan Sheet

Executive Summary

Settlement agreement between Bausch & Lomb and Alcon Labs establishes a cross-licensing relationship that allows Alcon to continue selling its ICAP AREDS ocular vitamins worldwide and gives B&L global rights under one or more Alcon patents. B&L filed an infringement suit against the ICAPS manufacturer shortly after receiving a patent for its Ocuvite PreserVision line of antioxidant and mineral eye vitamins in December 2003. The formula was developed by B&L and the National Eye Institute for use in NEI's Age-Related Eye Disease Study (AREDS) and remains the only vitamin demonstrated effective in preserving eye health and vision (1"The Tan Sheet" Oct. 15, 2001, p. 3)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS097997

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel